Psychedelic Medicine Operations — CicadenceEsketamine showed what happens when regulated, in-clinic medicine arrives without the operational layer to run it. Cicadence is the queue, staffing, and compliance layer for the psychedelic medicine programs coming next.What Went Wrong With EsketamineThe drug worked; the rollout stalled for years because the operational requirements landed on clinics with no infrastructure for them: REMS-certified site requirements tracked in spreadsheets, 2-hour monitored observation sessions that turn every dose into a scheduling problem, dosing room capacity ceilings, credentialed observer staffing gaps, and heavy benefits investigation and prior authorization burden on an expensive in-clinic drug.What's Coming

Psilocybin — FDA rolling review, projected 2027 launch, monitored in-clinic administration.

5-MeO-DMT — Eli Lilly acquired AtaiBeckley in July 2026; Phase 3; shorter sessions, same in-clinic pattern.

MDMA and other candidates moving through trials with the same operational shape.

Treatment centers and specialty pharmacies are standing up programs now. Drug program names are those of their respective sponsors; their mention does not imply any partnership or endorsement.What Cicadence Provides From Day One

Dosing room and monitor scheduling with credential verification

REMS enrollment queue tracking with live counts and assignments

Prior authorization and benefits investigation queues — live volume, per-queue processing rates, and a required-staffing calculation compared against current assignments

Fatigue and consecutive-shift flags — a separate schedule check that runs alongside the staffing numbers

Audit-ready compliance reporting with a full audit trail

Queue data comes in through CSV import, a public REST API, or inbound webhooks — no core system replacement.Design Partner ProgramWe're selecting 3 design partners — esketamine treatment centers and specialty pharmacies preparing for psychedelic medicine programs. Read-only pilot, no core system replacement. Apply to be a design partner.